ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,629, issued on Aug. 12, was assigned to Arizona Board of Regents on behalf of Arizona State University (Scottsdale, Ariz.).
"DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2" was invented by Sidney Hecht (Phoenix) and Shengxi Chen (Chandler, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are therapeutic agents having specificity for having inhibitory activity against cancer cells that overexpress human epidermal growth factor receptor (HER) genes, including therapeutic agents comprising one or more HER-targeting peptides, pharmaceutical compositions comprising such therapeutic ag...